http://orcid.org/0000-0002-5969-6407
References
- O’Neill, J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev. Antimicrob. Resist.20, 1–16 (2014).
- de KrakerMEStewardsonAJHarbarthSWill 10 million people die a year due to antimicrobial resistance by 2050?PLoS Med.201613 e100218410.1371/journal.pmed.10021845127510
- BoucherHWBad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of AmericaClin. Infect. Dis.2009481 1210.1086/595011
- WHO Publishes List of Bacteria for which New Antibiotics are Urgently Needed2017Geneva,WHO
- AntunesLCViscaPTownerKJAcinetobacter baumannii: evolution of a global pathogenPathog. Dis.20147129230110.1111/2049-632X.12125
- D’ArezzoSEpidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy)Clin. Microbiol. Infect.20091534735710.1111/j.1469-0691.2009.02668.x
- PotronAPoirelLNordmannPEmerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiologyInt. J. Antimicrob. Agents20154556858510.1016/j.ijantimicag.2015.03.001
- NationRLFramework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensusLancet Infect. Dis.20151522523410.1016/S1473-3099(14)70850-3
- QureshiZAColistin-resistant Acinetobacter baumannii: beyond carbapenem resistanceClin. Infect. Dis.2015601295130310.1093/cid/civ0484462660
- MorganDJNon-prescription antimicrobial use worldwide: a systematic reviewLancet Infect. Dis.20111169270110.1016/S1473-3099(11)70054-83543997
- CizmanMAntibiotic policies in Central Eastern EuropeInt. J. Antimicrob. Agents20042419920410.1016/j.ijantimicag.2004.03.016
- FishbainJPelegAYTreatment of acinetobacter infectionsClin. Infect. Dis.201051798410.1086/653120
- BryceAGlobal prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysisBMJ2016352i93910.1136/bmj.i9394793155
- Higgins, J. P. & Green, S. Cochrane handbook for systematic reviews of interventions version 5.1. 0. The cochrane collaboration5, (2011). www.handbook.cochrane.org.
- MoherDPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253510.1136/bmj.b25352714657
- ViechtbauerWConducting meta-analyses in R with the metafor packageJ. Stat. Softw.20103614810.18637/jss.v036.i03
- TasinaEEfficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysisLancet Infect. Dis.20111183484410.1016/S1473-3099(11)70177-3
- NiWTigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysisInt. J. Antimicrob. Agents20164710711610.1016/j.ijantimicag.2015.11.011
- FitzpatrickMAInfluence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistanceJ. Infect.20157014415210.1016/j.jinf.2014.09.004
- KarlowskyJASurveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001Antimicrob. Agents Chemother.2003471681168810.1128/AAC.47.5.1681-1688.2003153334
- TanREpidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in ShanghaiJ. Microbiol. Immunol. Infect.201447879410.1016/j.jmii.2012.11.006
- MahamatAClinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008–2014Int. J. Antimicrob. Agents201648515510.1016/j.ijantimicag.2016.03.006
- GogouVEvolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)J. Antimicrob. Chemother.2011662767277210.1093/jac/dkr390
- VillalonPClonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in SpainJ. Clin. Microbiol.20114987588210.1128/JCM.01026-103067678
- Da SilvaGJSequence types of Portuguese carbapenem-resistant Acinetobacter baumannii isolates collected over 10 yearsJ. Antimicrob. Chemother.2010652254225610.1093/jac/dkq274
- Di PopoloAMolecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing schemeClin. Microbiol. Infect.20111719720110.1111/j.1469-0691.2010.03254.x
- DiancourtLThe population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic poolPLoS One20105e1003410.1371/journal.pone.00100342850921
- van DesselHIdentification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitalsRes. Microbiol.200415510511210.1016/j.resmic.2003.10.003
- PourhajibagherMAntimicrobial resistance of Acinetobacter baumannii to Imipenem in Iran: a systematic review and meta-analysisOpen Microbiol. J.201610324210.2174/18742858016100100324814728
- CantonRRapid evolution and spread of carbapenemases among Enterobacteriaceae in EuropeClin. Microbiol. Infect.20121841343110.1111/j.1469-0691.2012.03821.x
- YilmazGCharacterization and toxicity of hospital wastewaters in TurkeyEnviron. Monit. Assess.201718910.1007/s10661-016-5732-2
- MarakiSEpidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram-negative bacilli isolated from patients treated on surgical wardsSurg. Infect.20121332633110.1089/sur.2011.115
- LazureanuVInfection with Acinetobacter baumannii in an intensive care unit in the Western part of RomaniaBMC Infect. Dis.20161610.1186/s12879-016-1399-04928153
- LeshoEEmergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infectionsJ. Infect. Dis.20132081142115110.1093/infdis/jit293